Insider · CIK 1106578
Martine A Rothblatt
Chairperson & CEO at United Therapeutics UTHR
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys0
Open-market sales168
Bought$0
Sold$76.2M
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 223 sh at $593.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $132K | 333,720 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 905 sh at $594.03 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $538K | 332,815 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,599 sh at $595.15 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $952K | 331,216 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 2,776 sh at $596.11 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $1.7M | 328,440 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 2,517 sh at $597.02 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $1.5M | 325,923 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,280 sh at $597.95 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $765K | 324,643 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 | United Therapeutics UTHR | Sold (10b5-1) 200 sh at $598.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $120K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 119 sh at $594.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $71K | 333,824 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 728 sh at $596.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $434K | 333,096 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 393 sh at $596.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $235K | 332,703 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,496 sh at $598.04 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $895K | 331,207 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 884 sh at $598.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $529K | 330,323 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,200 sh at $600.25 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $720K | 329,123 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,742 sh at $600.96 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $1M | 327,381 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 2,018 sh at $601.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $1.2M | 325,363 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 577 sh at $603.13 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $348K | 324,786 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 183 sh at $603.89 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $111K | 324,603 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 40 sh at $605.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $24K | 324,563 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 80 sh at $606.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $49K | 324,483 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 30, 2026 | United Therapeutics UTHR | Sold (10b5-1) 40 sh at $608.05 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. | $24K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 8 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 53 sh at $590.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $31K | 333,890 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,104 sh at $591.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $653K | 332,786 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,563 sh at $592.97 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $927K | 331,223 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,540 sh at $593.88 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $915K | 329,683 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,248 sh at $594.89 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $742K | 328,435 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,678 sh at $595.88 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $1M | 326,757 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,355 sh at $596.86 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $809K | 325,402 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 919 sh at $597.66 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $549K | 324,483 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 29, 2026 | United Therapeutics UTHR | Sold (10b5-1) 40 sh at $599.30 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. | $24K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 7 days after the company's 8-K filed Oct 22, 2026. |
| Oct 28, 2026 | United Therapeutics UTHR | Sold (10b5-1) 821 sh at $583.50 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. | $479K | 333,122 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. |
| Oct 28, 2026 | United Therapeutics UTHR | Sold (10b5-1) 2,625 sh at $584.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. | $1.5M | 330,497 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. |
| Oct 28, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,902 sh at $585.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. | $1.1M | 328,595 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. |
| Oct 28, 2026 | United Therapeutics UTHR | Sold (10b5-1) 3,086 sh at $586.37 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. | $1.8M | 325,509 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. |
| Oct 28, 2026 | United Therapeutics UTHR | Sold (10b5-1) 986 sh at $587.27 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. | $579K | 324,523 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. |
| Oct 28, 2026 | United Therapeutics UTHR | Sold (10b5-1) 80 sh at $588.39 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. | $47K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 89 sh at $582.66 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $52K | 333,854 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 807 sh at $583.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $471K | 333,047 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,417 sh at $584.83 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $829K | 331,630 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 470 sh at $585.72 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $275K | 331,160 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,417 sh at $586.93 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $832K | 329,743 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,320 sh at $587.88 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $776K | 328,423 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,597 sh at $588.95 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $941K | 326,826 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,003 sh at $589.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $592K | 325,823 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 700 sh at $590.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $414K | 325,123 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 600 sh at $592.05 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $355K | 324,523 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 27, 2026 | United Therapeutics UTHR | Sold (10b5-1) 80 sh at $592.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. | $47K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 600 sh at $585.71 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $351K | 333,343 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,492 sh at $586.54 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $875K | 331,851 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 2,707 sh at $587.54 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $1.6M | 329,144 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,241 sh at $588.47 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $730K | 327,903 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,280 sh at $589.64 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $755K | 326,623 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 680 sh at $590.57 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $402K | 325,943 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 694 sh at $591.60 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $411K | 325,249 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 26, 2026 | United Therapeutics UTHR | Sold (10b5-1) 806 sh at $592.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. | $478K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 200 sh at $577.68 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $116K | 333,743 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 700 sh at $578.80 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $405K | 333,043 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,038 sh at $579.74 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $602K | 332,005 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,017 sh at $580.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $591K | 330,988 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,650 sh at $581.82 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $960K | 329,338 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,732 sh at $582.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $1M | 327,606 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 427 sh at $583.83 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $249K | 327,179 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 676 sh at $584.77 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $395K | 326,503 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 778 sh at $585.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $456K | 325,725 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 542 sh at $586.93 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $318K | 325,183 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 23, 2026 | United Therapeutics UTHR | Sold (10b5-1) 740 sh at $588.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. | $435K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 74 sh at $562.97 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $42K | 333,869 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 110 sh at $563.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $62K | 333,759 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $565.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $90K | 333,599 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $570.08 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $91K | 333,439 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $571.77 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $91K | 333,279 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 40 sh at $573.39 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $23K | 333,239 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 130 sh at $575.32 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $75K | 333,109 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 190 sh at $576.80 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $110K | 332,919 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 280 sh at $577.28 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $162K | 332,639 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $578.59 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $93K | 332,479 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $579.69 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $93K | 332,319 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 360 sh at $581.03 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $209K | 331,959 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 400 sh at $581.83 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $233K | 331,559 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 760 sh at $583.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $443K | 330,799 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,200 sh at $584.21 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $701K | 329,599 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,756 sh at $585.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $1M | 327,843 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,280 sh at $586.31 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $750K | 326,563 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 937 sh at $587.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $550K | 325,626 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 783 sh at $588.19 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $461K | 324,843 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 240 sh at $589.50 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $141K | 324,603 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 22, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $590.40 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. | $94K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 22, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 46 sh at $552.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $25K | 333,897 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 194 sh at $553.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $107K | 333,703 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 550 sh at $555.19 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $305K | 333,153 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 567 sh at $556.41 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $315K | 332,586 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,702 sh at $557.25 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $948K | 330,884 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,137 sh at $558.32 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $635K | 329,747 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 743 sh at $559.25 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $416K | 329,004 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 820 sh at $560.50 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $460K | 328,184 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 200 sh at $561.44 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $112K | 327,984 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 960 sh at $562.54 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $540K | 327,024 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,253 sh at $563.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $706K | 325,771 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 768 sh at $564.63 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $434K | 325,003 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 480 sh at $565.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $271K | 324,523 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 21, 2026 | United Therapeutics UTHR | Sold (10b5-1) 80 sh at $566.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $45K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 117 sh at $546.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $64K | 333,826 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 575 sh at $547.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $315K | 333,251 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 948 sh at $548.95 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $520K | 332,303 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 586 sh at $550.02 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $322K | 331,717 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,134 sh at $551.03 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $625K | 330,583 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,560 sh at $551.85 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $861K | 329,023 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 240 sh at $553.14 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $133K | 328,783 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,260 sh at $553.97 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $698K | 327,523 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $555.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $89K | 327,363 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 440 sh at $556.06 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $245K | 326,923 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 320 sh at $557.12 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $178K | 326,603 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 520 sh at $558.72 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $291K | 326,083 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 280 sh at $559.70 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $157K | 325,803 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 315 sh at $560.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $177K | 325,488 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 360 sh at $561.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $202K | 325,128 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 464 sh at $562.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $261K | 324,664 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 20, 2026 | United Therapeutics UTHR | Sold (10b5-1) 221 sh at $563.56 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $125K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $534.75 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $86K | 333,783 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 360 sh at $536.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $193K | 333,423 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 240 sh at $537.11 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $129K | 333,183 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 160 sh at $538.54 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $86K | 333,023 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 880 sh at $539.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $475K | 332,143 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,800 sh at $540.63 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $973K | 330,343 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 520 sh at $541.38 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $282K | 329,823 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 260 sh at $542.81 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $141K | 329,563 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,240 sh at $543.73 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $674K | 328,323 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,040 sh at $544.89 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $567K | 327,283 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,065 sh at $545.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $581K | 326,218 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 416 sh at $547.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $228K | 325,802 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 559 sh at $547.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $306K | 325,243 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 360 sh at $549.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $198K | 324,883 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 120 sh at $549.66 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $66K | 324,763 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 80 sh at $551.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $44K | 324,683 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 40 sh at $552.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $22K | 324,643 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 120 sh at $554.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $66K | 324,523 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 19, 2026 | United Therapeutics UTHR | Sold (10b5-1) 80 sh at $556.88 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $45K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 4 days after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 240 sh at $530.48 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $127K | 333,703 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,024 sh at $531.54 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $544K | 332,679 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 2,378 sh at $532.46 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $1.3M | 330,301 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 1,818 sh at $533.32 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $970K | 328,483 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 640 sh at $534.41 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $342K | 327,843 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 535 sh at $535.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $287K | 327,308 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 865 sh at $536.66 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $464K | 326,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 760 sh at $537.74 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $409K | 325,683 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 401 sh at $538.55 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $216K | 325,282 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 239 sh at $539.60 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $129K | 325,043 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 169 sh at $541.62 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $92K | 324,874 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 391 sh at $542.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $212K | 324,483 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Oct 16, 2026 | United Therapeutics UTHR | Sold (10b5-1) 40 sh at $543.85 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. | $22K | 324,443 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Oct 15, 2026. |
| Nov 17, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,500 sh at $466.26 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 17, 2025. | $699K | 2,630 −36% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 17, 2025. |
| Nov 17, 2025 | United Therapeutics UTHR | Sold (10b5-1) 2,500 sh at $468.32 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 17, 2025. | $1.2M | 130 −95% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 17, 2025. |
| Nov 14, 2025 | United Therapeutics UTHR | Sold (10b5-1) 500 sh at $460.34 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. | $230K | 3,630 −12% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. |
| Nov 14, 2025 | United Therapeutics UTHR | Sold (10b5-1) 2,000 sh at $461.83 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. | $924K | 1,630 −55% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. |
| Nov 14, 2025 | United Therapeutics UTHR | Sold (10b5-1) 930 sh at $464.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. | $432K | 700 −57% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. |
| Nov 14, 2025 | United Therapeutics UTHR | Sold (10b5-1) 570 sh at $466.05 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. | $266K | 130 −81% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 14, 2025. |
| Oct 30, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,500 sh at $447.14 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. | $671K | 2,630 −36% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. |
| Oct 30, 2025 | United Therapeutics UTHR | Sold (10b5-1) 541 sh at $448.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. | $243K | 2,089 −21% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. |
| Oct 30, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,459 sh at $450.23 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. | $657K | 630 −70% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. |
| Oct 30, 2025 | United Therapeutics UTHR | Sold (10b5-1) 500 sh at $451.29 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. | $226K | 130 −79% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 30, 2025. |
| Oct 29, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,100 sh at $433.31 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 29, 2025. | $477K | 3,030 −27% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 29, 2025. |
| Oct 29, 2025 | United Therapeutics UTHR | Sold (10b5-1) 2,000 sh at $435.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 29, 2025. | $870K | 1,030 −66% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 29, 2025. |
| Oct 29, 2025 | United Therapeutics UTHR | Sold (10b5-1) 900 sh at $439.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 29, 2025. | $396K | 130 −87% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Oct 29, 2025. |
| Oct 28, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,991 sh at $413.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 28, 2025. | $823K | 2,139 −48% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 28, 2025. |
| Oct 28, 2025 | United Therapeutics UTHR | Sold (10b5-1) 509 sh at $415.02 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 28, 2025. | $211K | 1,630 −24% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 28, 2025. |
| Oct 28, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,500 sh at $417.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 28, 2025. | $627K | 130 −92% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 28, 2025. |
| Oct 27, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,000 sh at $411.95 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 27, 2025. | $412K | 3,130 −24% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 27, 2025. |
| Oct 27, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,814 sh at $414.42 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 27, 2025. | $752K | 1,316 −58% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 27, 2025. |
| Oct 27, 2025 | United Therapeutics UTHR | Sold (10b5-1) 1,186 sh at $420.29 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 27, 2025. | $498K | 130 −90% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 27, 2025. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.